Jay Bauder, MD
Family Medicine · Alexandria, MNNPI 1972737054
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 9 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 7 manufacturers reported payments, led by Lundbeck LLC at 27.1% of the total.
Across 9 payments — averaging $15.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lundbeck LLC$37
- Exact Sciences$29
- Boston Scientific$22
- E.r. Squibb & Sons, L.L.C.$15
- Otsuka America Pharmaceutical, Inc.$14
- AstraZeneca$14
- plus $7 from 1 others
What the payments were for
- Food & beverage$137100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lundbeck LLC | 2 | $37 |
| Exact Sciences | 2 | $29 |
| Boston Scientific | 1 | $22 |
| E.r. Squibb & Sons, L.L.C. | 1 | $15 |
| Otsuka America Pharmaceutical, Inc. | 1 | $14 |
| AstraZeneca | 1 | $14 |
| Phathom Pharmaceuticals, Inc. | 1 | $7 |
How this compares
$137 in reported general payments places this provider in the 70th percentile of 1,162 family medicine providers in Minnesota.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 53 | $59,024 |
| OzempicSemaglutide | 30 | $52,603 |
| XareltoRivaroxaban | 39 | $46,983 |
| JardianceEmpagliflozin | 23 | $28,316 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 31 | $24,967 |
| MyrbetriqMirabegron | 17 | $9,235 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 14 | $6,349 |
| Stiolto RespimatTiotropium Br/Olodaterol Hcl | 13 | $6,184 |
| Atorvastatin Calcium | 390 | $5,614 |
| DexilantDexlansoprazole | 13 | $3,840 |
| Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate | 12 | $3,673 |
| Ventolin HfaAlbuterol Sulfate | 47 | $3,354 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 17 | $2,832 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 14 | $2,273 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 51 | $2,116 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Alexandria
- Susan PaulsonAlexandria$4K
- Amanda LovoldSt Cloud$387K
- Robert MarshMinnetonka$300K
- Taylor MertzMoorhead$176K
- Justin YoungTracy$93K
- Gerard SpoelhofDuluth$75K
- Martha MasciopintoCottage Grove$50K
- Glenn DetlefsenRosemount$39K
- Amy GilbertSaint Paul$27K
- Kevin PetersonMinneapolis$25K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.